Adherence and persistence with oral adjuvant chemotherapy in older women with early-stage breast cancer in CALGB 49907: adherence companion study 60104 - Wikidata - awgldk - TriplyDB

Adherence and persistence with oral adjuvant chemotherapy in older women with early-stage breast cancer in CALGB 49907: adherence companion study 60104

Adherence and persistence with oral adjuvant chemotherapy in older women with early-stage breast cancer in CALGB 49907: adherence companion study 60104

http://www.wikidata.org/entity/Q33897610

about

Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer Factors influencing adherence to cancer treatment in older adults with cancer: a systematic review Oral antineoplastic agents: how do we care about adherence?Adherence with capecitabine: A population-based analysis based on prescription refill data.The best treatment for older patients with breast cancer.Impact of pharmacy channel on adherence to oral oncolytics.Optimizing adherence to adjuvant imatinib in gastrointestinal stromal tumor.Oral anticancer agent medication adherence by outpatients Perspectives on adherence and persistence with oral medications for cancer treatment.The change from brand-name to generic aromatase inhibitors and hormone therapy adherence for early-stage breast cancer.Household net worth, racial disparities, and hormonal therapy adherence among women with early-stage breast cancer.Patients' self-reported adherence to capecitabine on XELOX treatment in metastatic colorectal cancer: findings from a retrospective cohort analysis.Adherence to oral anticancer chemotherapy: What influences patients' over or non-adherence? Analysis of the OCTO study through quantitative-qualitative methods.Adherence and awareness of the therapeutic intent of oral anticancer agents in an outpatient setting Adherence, exposure and patients' experiences with the use of erlotinib in non-small cell lung cancer.Compliance with adjuvant capecitabine in patients with stage II and III colon cancer: comparison of administrative versus medical record data.The use of capecitabine in daily practice: a study on adherence and patients' experiences Persistence, adherence, and toxicity with oral CMF in older women with early-stage breast cancer (Adherence Companion Study 60104 for CALGB 49907)"Keeping the Boogie Man Away": Medication Self-Management among Women Receiving Anastrozole Therapy.A Systematic Review of Adherence to Oral Antineoplastic Therapies Senior adult oncology.Patient-oncologist alliance, psychosocial well-being, and treatment adherence among young adults with advanced cancer.Definitions, variants, and causes of nonadherence with medication: a challenge for tailored interventions Adherence management for patients with cancer taking capecitabine: a prospective two-arm cohort study.Initiation of adjuvant hormone therapy by Medicaid insured women with nonmetastatic breast cancer.Oral cancer chemotherapy adherence and adherence assessment tools: a report from North Central Cancer Group Trial N0747 and a systematic review of the literature.Effect of age on drug metabolism in women with breast cancer.Disease acceptance and adherence to imatinib in Taiwanese chronic myeloid leukaemia outpatients.Adherence, compliance and persistence to oral antineoplastic therapy: a review focused on chemotherapeutic and biologic agents.Adherence to oral antineoplastic agents by cancer patients: definition and literature review.Adherence and patients' experiences with the use of oral anticancer agents.Improving adherence to oral cancer therapy in clinical practice.Impact of a specialty pharmacy case management service on adherence in patients receiving oral antineoplastic agents.Early breast cancer in the older woman.Capecitabine non-adherence: exploration of magnitude, nature and contributing factors.The effect of medication nonadherence on progression-free survival among patients with renal cell carcinoma.Impact of persistence on survival of patients with breast cancer treated with endocrine therapy in Northeast China: a prospective study.Delivery of adjuvant chemotherapy among stage III colon cancer patients at a public versus private hospital in New York City.Patient-doctor relationship and adherence to capecitabine in outpatients of a German comprehensive cancer center Assessing adherence to oral chemotherapy using different measurement methods: Lessons learned from capecitabine

P2860

Q24632347-F6DB4758-07E5-4184-93CA-2D7C84C6C3C5 Q26850736-1D5B9015-6707-46F1-AD05-2C976D288CA2 Q28082909-D4BF930D-868D-4D42-A9AA-4295EB1C27E9 Q31140272-1DC8D07C-BF6F-4EB9-BDBC-BD40980EF1A9 Q33697318-F7FF67CA-0344-470E-94A5-28AFD7E141C7 Q33815415-D66DC4E9-6F18-4590-873B-FAC5BD3B0B2F Q33885999-FF4FEAEF-320C-4C25-82E1-93E2C8F864A5 Q34293339-CF63D3B1-C23D-4330-B385-A196D34DAABB Q34459748-11496BF9-B309-499D-92FF-A755DFCD2A86 Q34736154-104192C1-62C3-469D-9F18-7C55770265AA Q35168777-B7913F50-F8F0-4939-90C9-577F8B443078 Q35444531-E816B047-9CBF-493B-8810-4DDEDA357694 Q35682644-00C3EBE1-7FF3-4CA9-AFF8-4E31DEB91AF5 Q35742246-9D591664-9B7C-4719-B235-3E18D275EF92 Q35749286-D4577B23-F66B-4D8F-96B0-20C2CE9FECF0 Q36030885-15D0477B-9679-4A17-B725-534D92264030 Q36358178-3AA57679-D1D9-46A0-AD7E-5692EB26C30E Q36408545-11DA229F-AFB5-4C04-A18A-03191017EB1F Q36528477-CE2533B2-983F-4548-84BA-D6690B44A9EC Q36673490-58B30DB4-4AB6-46D9-954D-B1585AE5EADE Q36851424-98A2E838-99D4-4778-8B80-94E791B57D88 Q36929706-33972E5B-04D0-47B0-898C-0156932C0695 Q37014474-AB8816F6-F3B8-4F4F-987C-B0D597193606 Q37029891-81455931-07E8-4D93-B68E-E7E546C061AD Q37064299-472A2FD8-3084-4B70-85EC-625E963366E6 Q37273881-7985C000-601E-4109-9B0F-F8E69E2CA940 Q37325560-9BA4E29C-52D5-4E30-88FD-B3368348F215 Q37471683-1CE15424-8894-4A29-B992-E468D72C43C9 Q37965653-2BC94C8E-531C-4E3A-8D07-2AEAB60E0BFF Q38147533-E2827941-DC86-4DD5-9581-63C2C5CE0B63 Q38165220-2C689EA8-407B-4403-AAA9-F6C147E659CE Q38216035-770EE0A8-959A-485F-AF61-7CA1102F2C8A Q38783329-4AA5FCE6-CECA-4553-A10A-4C96865506B5 Q39653595-2EE8C9F1-264C-4B33-8181-2D8DF3056C36 Q44141281-1D38AB8A-CA03-4589-A436-A3CFC776CC9E Q45972439-250C1E49-11DD-4804-9587-FC8526CB82C7 Q47112006-070DBF0C-3C7C-4D1D-981C-566F4AF7A3D6 Q47776943-8E15C858-09CE-4305-8F85-258C778906F2 Q57071452-4C56A8C2-870E-430D-A768-FF016BFC1FA8 Q58819316-E7861CAB-85AB-4F40-A253-E0BB5D54F1C7

P2860

Adherence and persistence with oral adjuvant chemotherapy in older women with early-stage breast cancer in CALGB 49907: adherence companion study 60104

http://www.wikidata.org/entity/Q33897610

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Adherence and persistence with ...... dherence companion study 60104

@ast

Adherence and persistence with ...... dherence companion study 60104

@en

type

label

Adherence and persistence with ...... dherence companion study 60104

@ast

Adherence and persistence with ...... dherence companion study 60104

@en

prefLabel

Adherence and persistence with ...... dherence companion study 60104

@ast

Adherence and persistence with ...... dherence companion study 60104

@en

P1433

Q33897610-04211AA9-1357-45AA-B2A7-DE7D5A4C607C

P1476

Q33897610-7726FFDD-A1A8-4F9B-A567-12E5EC2DA1F8

P2093

Q33897610-0E8993CC-406B-4159-A565-0B987C44D328

Q33897610-0E96E660-848B-441C-B088-82074C3344AE

Q33897610-14C67A8E-7FFC-4BDD-9306-B303C2C2F6F5

Q33897610-17E26CC6-13DA-43DF-B658-3C1FDCEED174

Q33897610-469889CF-7674-470C-9BBC-5C532FFD5C06

Q33897610-4988B1FA-E85C-4898-93F5-172065767639

Q33897610-4C534CDE-21EE-431F-9EE5-37561FCA9C1C

Q33897610-568B2FA4-783B-4AF1-80A6-1893C92F8943

Q33897610-68E1B333-65AC-4349-8C3F-3D880AD2D761

Q33897610-A1B0F4E4-8C16-45D7-B4D5-789FCA25A917

P2860

Q33897610-0331993B-6008-4E44-8213-A8C8B4B2A403

Q33897610-0780D1A7-E00B-4249-B0EE-40B25003FB18

Q33897610-1FF245DF-2BED-46D6-B5D1-A647F9A057C6

Q33897610-3A8FD972-DAF8-42E4-8222-7D799D4A5104

Q33897610-4A027781-437F-4CCE-838E-D4C9300FED7E

Q33897610-5A18A7C0-8D90-4A57-B7AA-CA8FFF423EDC

Q33897610-85D85E7F-CA97-46A4-AC4D-75964E71F34E

Q33897610-8695A229-D276-442E-A19D-E8547473945A

Q33897610-932D8E86-84C6-4ACA-911F-98503B6A9FB3

Q33897610-96391FB9-DB63-4418-A7F5-AD33F6C4ADC5

P304

Q33897610-055E6808-570E-41E7-B817-016F7D90F130

P31

Q33897610-8617B986-6BE1-40D8-84E1-0903BB8D9A18

P356

Q33897610-30F5988F-DC3E-4B78-A88F-7F0F31ED8E3D

P407

Q33897610-08AF0793-3ECE-472F-9422-276D139A63D7

P433

Q33897610-637B2403-CDE1-4D63-8DAF-FD239CFCDDA2

P478

Q33897610-FEF4F5B0-0FC0-40F3-941C-06EA8AC1FC31

P50

Q33897610-F08B2780-289E-4FE7-B121-F6F732F86F27

P577

Q33897610-7A91EC24-44F5-48AD-8EBD-258E977CC817

P698

Q33897610-8D4BB77F-228D-4EA5-A298-D050D0C11FE1

P921

Q33897610-053DA648-9B6B-42C7-B13A-72EF8E9B655F

P932

Q33897610-88D2B4B6-45A9-4322-99EF-F4C0CF19406E

P356

JCO.2009.26.4671

P1433

Journal of Clinical Oncology

P1476

Adherence and persistence with ...... dherence companion study 60104

@en

P2093

Alice B Kornblith

http://www.w3.org/2001/XMLSchema#string

Ann H Partridge

http://www.w3.org/2001/XMLSchema#string

Clifford Hudis

http://www.w3.org/2001/XMLSchema#string

Debjani Grenier

http://www.w3.org/2001/XMLSchema#string

Donald Berry

http://www.w3.org/2001/XMLSchema#string

Edith Perez

http://www.w3.org/2001/XMLSchema#string

Eric Winer

http://www.w3.org/2001/XMLSchema#string

Helen Kastrissios

http://www.w3.org/2001/XMLSchema#string

Hyman Muss

http://www.w3.org/2001/XMLSchema#string

Julie Gralow

http://www.w3.org/2001/XMLSchema#string

P2860

Adherence to therapy with oral antineoplastic agents

A systematic review of the associations between dose regimens and medication compliance.

Adjuvant tamoxifen: predictors of use, side effects, and discontinuation in older women.

How often is medication taken as prescribed? A novel assessment technique.

Adjuvant chemotherapy in older women with early-stage breast cancer.

Tolerability of and adherence to combination oral therapy with gefitinib and capecitabine in metastatic breast cancer

Adherence to endocrine therapy for breast cancer.

Use of electronic monitoring in clinical nursing research.

Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer

Medication compliance and persistence: terminology and definitions.

P304

2418-2422

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2009.26.4671

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

Antonio C. Wolff

P577

2010-04-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20368559

http://www.w3.org/2001/XMLSchema#string

P921

P932

2881723

http://www.w3.org/2001/XMLSchema#string